2-38937386-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001145451.5(ARHGEF33):c.617C>T(p.Ser206Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000171 in 1,460,780 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000014 ( 0 hom., cov: 28)
Exomes 𝑓: 0.000017 ( 0 hom. )
Consequence
ARHGEF33
NM_001145451.5 missense
NM_001145451.5 missense
Scores
1
16
Clinical Significance
Conservation
PhyloP100: 3.67
Genes affected
ARHGEF33 (HGNC:37252): (Rho guanine nucleotide exchange factor 33) Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of catalytic activity. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0906125).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGEF33 | NM_001145451.5 | c.617C>T | p.Ser206Leu | missense_variant | 9/18 | ENST00000409978.7 | NP_001138923.2 | |
LOC105374471 | XR_939980.3 | n.111-934G>A | intron_variant, non_coding_transcript_variant | |||||
ARHGEF33 | NM_001367623.3 | c.617C>T | p.Ser206Leu | missense_variant | 9/19 | NP_001354552.1 | ||
LOC105374471 | XR_001739417.1 | n.163G>A | non_coding_transcript_exon_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF33 | ENST00000409978.7 | c.617C>T | p.Ser206Leu | missense_variant | 9/18 | 5 | NM_001145451.5 | ENSP00000387020 | P1 | |
ARHGEF33 | ENST00000698009.1 | c.761C>T | p.Ser254Leu | missense_variant | 10/19 | ENSP00000513494 | ||||
ARHGEF33 | ENST00000398800.8 | c.617C>T | p.Ser206Leu | missense_variant | 7/16 | 5 | ENSP00000381780 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000138 AC: 2AN: 144518Hom.: 0 Cov.: 28
GnomAD3 genomes
AF:
AC:
2
AN:
144518
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000129 AC: 2AN: 155222Hom.: 0 AF XY: 0.0000243 AC XY: 2AN XY: 82298
GnomAD3 exomes
AF:
AC:
2
AN:
155222
Hom.:
AF XY:
AC XY:
2
AN XY:
82298
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000175 AC: 23AN: 1316262Hom.: 0 Cov.: 31 AF XY: 0.0000139 AC XY: 9AN XY: 648054
GnomAD4 exome
AF:
AC:
23
AN:
1316262
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
648054
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000138 AC: 2AN: 144518Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 69808
GnomAD4 genome
AF:
AC:
2
AN:
144518
Hom.:
Cov.:
28
AF XY:
AC XY:
0
AN XY:
69808
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.617C>T (p.S206L) alteration is located in exon 7 (coding exon 7) of the ARHGEF33 gene. This alteration results from a C to T substitution at nucleotide position 617, causing the serine (S) at amino acid position 206 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N
MutationTaster
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Vest4
MVP
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at